Summary & Overview
CPT 80363: Opioid Panel, 3–4 Analytes
CPT code 80363 represents a clinical laboratory toxicology assay that detects or quantifies three or four opioid and opiate analogs in a patient specimen. This test is widely used in clinical care, pain management programs, substance use monitoring, and workplace or forensic contexts to identify opioid exposure and guide subsequent clinical or case management decisions. Nationally, opioid toxicology testing remains a significant component of laboratory utilization given ongoing efforts to monitor opioid prescribing and patient safety.
Key payers addressed in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The code’s coverage and reimbursement patterns vary by payer and setting, with distinctions commonly drawn between outpatient and inpatient laboratory channels and clinical versus forensic use cases.
Readers will find a concise explanation of the clinical context for CPT code 80363, typical sites of service, common payer inclusion, and benchmarks where available. The publication also outlines policy-relevant considerations such as coding specificity for panels of multiple opioid analytes, billing practice implications, and areas where documentation or test ordering context affects coverage. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 80363 describes a laboratory test in which the lab analyst measures the amount of, or detects the presence of, three or four opioids and opiate analogs (narcotic analgesics that depress the central nervous system) in a patient specimen. This is a toxicology panel focused on multiple opioid analytes used to identify exposure to or use of opioids and their analogs.
-
Service type: Clinical laboratory toxicology assay
-
Typical site of service: Hospital or independent clinical laboratory, outpatient laboratory draw sites, and other ambulatory collection settings
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting for toxicology testing after suspected opioid exposure, pain management monitoring, workplace drug screening, or evaluation following intoxication or overdose. The clinician (emergency physician, primary care provider, pain management specialist, occupational medicine clinician, or addiction medicine provider) orders a urine or serum drug test targeting multiple opioids/opiate analogs. A phlebotomist or clinic staff collects the specimen and sends it to a clinical laboratory. In the lab, a trained laboratory analyst performs a definitive or screening assay that detects or quantifies three or four opioids and opiate analogs (for example morphine, codeine, hydrocodone, oxycodone, fentanyl analogs depending on assay panels). Results are returned to the ordering clinician for interpretation and documentation in the medical record; positive findings may prompt confirmatory testing, medication reconciliation, changes to pain management, substance use interventions, or workplace/certification actions. Typical sites of service include hospital laboratories, independent reference laboratories, outpatient clinic collection sites, emergency departments, and occupational health clinics.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard reporting | Use when no special circumstance or modifier applies. |